Abiopharma

Insulet - Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

Agenus Inc. - Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026

Autolus Therapeutics to Participate in Upcoming Investor Conference

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Satellos to Present Clinical Program Updates at ICNMD 2026

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani

Dollar Tree Announces Secondary Block Trade by Selling Stockholders and Share Buyback